EVMNEVMNNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
3.89%
↓ 89% vs avg
Percentile
P67
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
35.68%
Historical baseline
PeriodValue
Q4 20253.89%
Q3 20250.01%
Q2 202536.74%
Q1 2025-7.70%
Q4 20240.00%
Q2 2024216.82%
Q1 20240.00%